Yoonhee Lee

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Systemic Lupus Erythematosus

Clinical Practice

Pulmonary Arterial Hypertension

Disease Activity

Top Venues

International journal of rheumatic diseases

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Chang-Hee Suh, Yoonhee Lee, Sang-Bae Yoo, Holly A Quasny, Aldo Amador Navarro Rojas, Anne Hammer, Yeong-Wook Song, Young Mo Kang, Chul-Soo Cho, Won Park, Seung Ki Kwok, Seung-Geun Lee, Won Tae Chung, Sang-Cheol Bae
Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia. International journal of rheumatic diseases 27 (1) (2023)
Chang-Hee Suh, Yoonhee Lee, Sang-Bae Yoo, Holly A Quasny, Aldo Amador Navarro Rojas, Anne Hammer, Yeong-Wook Song, Young Mo Kang, Chul-Soo Cho, Won Park, Seung Ki Kwok, Seung-Geun Lee, Won Tae Chung, Sang-Cheol Bae
Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia. International journal of rheumatic diseases 27 (1) (2023)
Chang-Hee Suh, Yoonhee Lee, Sang-Bae Yoo, Holly A Quasny, Aldo Amador Navarro Rojas, Anne Hammer, Yeong-Wook Song, Young Mo Kang, Chul-Soo Cho, Won Park, Seung Ki Kwok, Seung-Geun Lee, Won Tae Chung, Sang-Cheol Bae
Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia. International journal of rheumatic diseases (2023)
Kina Jeon, Sang-Bae Yoo, Yoonhee Lee, Eun-Bin Lee, Hyung Kwan Kim, Seo Young Song, Sung-A Chang
Safety and effectiveness of ambrisentan in real clinical practice in pulmonary arterial hypertension: Results from the Korean post-marketing surveillance. Pharmacoepidemiology and drug safety (2023)